"Strategic addition of an N-linked glycan to a monoclonal antibody improves its HIV-1-neutralizing activity", Nature Biotechnology

2013-10-01

"Strategic addition of an N-linked glycan to a monoclonal antibody improves its HIV-1-neutralizing activity",
Nature Biotechnology

http://www.nature.com/nbt/journal/v31/n11/full/nbt.2677.html